Pharmaceuticals Supplements Medical Devices

About Us Careers FAQ All Insights

Privacy Policy Terms of Service

Thai FDA Drug Registration Local Authorized Representative (LAR) & Importer of Record (IOR) Dossier Preparation, ACTD Submissions & Thai Labeling GMP Compliance Consulting Post-Approval Lifecycle Management Pharmacovigilance Government Fee Schedule Pharmaceutical Insights

Thai FDA Supplement Registration Local Importer & Orr.7 Import License GMP Requirements for Supplement Manufacturers Labeling & Health Claims Ingredient Approval & Novel Food Advertising Approval & the Kho Or Permit Supplement Insights

Thai FDA Medical Device Registration Device Classification: AMDD Classes 1-4 Local License Holder & Establishment Licensing Technical File & CSDT Preparation Labeling Requirements: B.E. 2568 (2025) Medical Device Insights

Email WhatsApp (+66) 082.208.2460

Thailand Regulatory
Insights

Stay current on Thai FDA enforcement, regulatory announcements, and ASEAN developments — then go deeper with our evergreen guides covering how the frameworks actually work. All content is organized by industry so you find what's relevant to your market without filtering through the rest.

Regulatory News & Updates

Pharmaceuticals

ICH E6(R3) Annex 2 Adopted at Step 4: The Final Good Clinical Practice Standard Is Now in Force ICH completed the E6(R3) revision, setting the final standard for Good Clinical Practice in clinical trials. Sponsors operating in Thailand must now align protocols, monitoring plans, and electronic systems to the new requirements.

US FDA Draft Guidance: Reduced Animal Testing for Oncology Biologics and What It Means for Thailand Dossiers FDA's draft guidance proposes reducing animal study requirements for oncology biologics based on mechanism of action. Companies filing in Thailand should assess how this shift affects nonclinical data expectations in their ACTD submissions.

US FDA Finalizes Postapproval Pregnancy Safety Studies Guidance: Thailand Pharmacovigilance Implications FDA's finalized guidance expands pharmacovigilance expectations for products used during pregnancy. Sponsors should review their signal detection and reporting obligations in Thailand in light of Thai FDA's ongoing alignment with international PV standards.

May 8, 2026 See All Pharmaceutical Insights

Supplements

Thai FDA Shuts Down VTEAY Online Stores: Counterfeit Registration Numbers in Supplement Distribution Thai FDA ordered the closure of VTEAY supplement stores after finding counterfeit registration numbers on distributed products. Every supplement importer and distributor operating in Thailand should audit their channel partners' registration credentials now.

EFSA Positive Safety Opinion on NMN: 300 mg/day Proposed and What It Means for Thai Supplement Companies EFSA issued a positive safety opinion on NMN at 300 mg per day, providing a scientific basis that may support health claims in regulated markets. Companies selling NMN products in Thailand should understand how this opinion interacts with Thai FDA's novel food and ingredient approval framework.

France Renews Garcinia Cambogia Supplement Ban Through April 2027: What Thai Exporters Must Know France extended its ban on Garcinia cambogia supplements for another year, citing unresolved hepatotoxicity concerns. Thai manufacturers and exporters supplying European markets should assess whether their product formulations address the ongoing regulatory scrutiny.

April 17, 2026 See All Supplement Insights

Medical Devices

US FDA Finalizes Human Factors Guidance for Device Submissions: Three-Category Framework Established FDA established a risk-based three-category framework for human factors documentation in device submissions, clarifying when full usability engineering is required. The standard is expected to reach Thai FDA CSDT review expectations within the next one to two regulatory cycles.

MDA Malaysia and Thai FDA Launch Full Bilateral Medical Device Reliance Programme Thailand and Malaysia formalized a bilateral reliance arrangement for medical device registrations, allowing Thai FDA to reference MDA decisions in its own review process. Companies with existing MDA approvals should assess whether the reliance pathway offers a faster route to Thai market entry.

IMDRF N93: The International AI Medical Device Lifecycle Framework Open for Public Consultation IMDRF released N93 for public comment, proposing a harmonized lifecycle framework for AI-enabled medical devices. The guidance will shape how Thai FDA evaluates Software as a Medical Device submissions as alignment with IMDRF principles continues.

April 10, 2026 See All Medical Device Insights

Regulatory Guides

Pharmaceuticals

ASEAN Common Technical Dossier (ACTD): What It Is and How It Applies to Thai Drug Registration The ACTD dossier is the required submission format for Thai FDA and differs from the ICH CTD used in Western markets. This guide covers Part I through Part IV structure, Thai-language requirements, and the formatting errors that most commonly cause screening failure.

Post-Approval Changes in Thailand: When You Need to Notify, Vary, or Re-Register Marketing authorization holders must notify or seek approval from Thai FDA before implementing manufacturing, formulation, or labeling changes. This guide covers the variation types, documentation requirements, and timelines for post-approval change management.

Thailand's Good Distribution Practice (GDP) Requirements for Pharmaceutical Importers Thai FDA's GDP requirements govern the storage, handling, and distribution of pharmaceutical products from import through to the end user. This guide covers facility standards, documentation requirements, and the compliance obligations that apply to licensed importers.

See All Pharmaceutical Insights

Supplements

Novel Food Ingredient Approval in Thailand: How Thai FDA Evaluates New Ingredients Before Market Entry Thai FDA evaluates novel food ingredients through a safety assessment process before they may be used in supplements sold in Thailand. This guide covers the novel food definition, the evaluation criteria, submission requirements, and which internationally approved novel foods have already received Thai FDA recognition.

Post-Market Surveillance Obligations for Food Supplement Importers Under Thai FDA Thai FDA imposes post-market surveillance obligations on food supplement license holders, including adverse event reporting and product monitoring. This guide covers the specific requirements, reporting timelines, and the compliance infrastructure foreign importers must maintain.

Thailand's Food Supplement Approval Pathway: Notification or Registration? Thai FDA distinguishes between food supplement notification and full registration, with different data requirements, timelines, and product eligibility. This guide explains which pathway applies to your product and what each requires.

See All Supplement Insights

Medical Devices

Thailand's Good Distribution Practice Requirements for Imported Medical Devices Thai FDA's GDP requirements for medical devices govern storage, handling, and distribution from the import point through to the end user. This guide covers the facility standards, temperature control requirements, and documentation practices that support GDP compliance for device importers.

Advertising Medical Devices in Thailand: What Requires Prior FDA Approval Medical device advertising in Thailand requires prior approval from Thai FDA before any promotional material is disseminated. This guide covers the advertising permit process, permitted claim types, channel-specific requirements, and the enforcement consequences of advertising without approval.

How Thailand Regulates Software as a Medical Device Under Current FDA Guidelines Software that qualifies as a medical device under Thai FDA's guidelines is subject to the same registration requirements as hardware devices. This guide covers the SaMD classification criteria, the registration pathway, and the specific technical documentation Thai FDA requires for software submissions.

See All Medical Device Insights